A new cancer therapy uses guided molecules to deliver radiation like a missile
Modern oncology is turning tumor markers into precision weapons by using guided molecules that deliver concentrated radiation directly to cancer cells while sparing the healthy tissue surrounding them.
Prostate-specific membrane antigen (PSMA) is a protein found on 90% of advanced prostate cancer cells, making it a perfect target for a new form of 'theranostics.' By attaching radioactive Lutetium-177 to molecules that seek out this protein, doctors can deliver beta radiation like a guided missile.
There's more to this story — open the app to keep reading.
Continue Reading in App
1 more paragraphs · plus a 2-question quiz